MORGAN STANLEY PLC/PUT/NOVARTIS N/80/0.1/20.12.24 Share Price

Warrant

DE000ME3BLE0

Market Closed - Börse Stuttgart 09:58:48 03/07/2024 pm IST
0.063 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/PUT/NOVARTIS N/80/0.1/20.12.24
Current month-5.97%
1 month-25.88%
Date Price Change
03/24/03 0.063 0.00%
02/24/02 0.063 -3.08%
01/24/01 0.065 -2.99%
28/24/28 0.067 -6.94%
27/24/27 0.072 +12.50%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 09:58 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVARTIS AG
Issuer Morgan Stanley
WKN ME3BLE
ISINDE000ME3BLE0
Date issued 09/11/2023
Strike 80 CHF
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 0.57
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.062
Delta-0.09x
Omega 13.43
Premium17.44x
Gearing147.49x
Moneyness 0.8324
Difference Strike -16.11 CHF
Difference Strike %-20.14%
Spread 0.012
Spread %16.44%
Theoretical value 0.0670
Implied Volatility 22.10 %
Total Loss Probability 88.19 %
Intrinsic value 0.000000
Present value 0.0670
Break even 79.35 €
Theta-0x
Vega0.01x
Rho-0x

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.7 USD
Average target price
110.3 USD
Spread / Average Target
+3.41%
Consensus